Emcure Pharma IPO Summary | CA Rachana Ranade

Correction:
🔴07:28 - Correction: from Generic* vs from Branded patented products.
Clarification- 09:08 - API image is taken from Emcure's website
Note: This is not a recommendation.

Watch this video to know more about the IPO of Emcure Pharma as we summarize the RHP details like Company details, Industry analysis, Financials and Valuation, Key risks, Peer comparison and other details.

--------------------------------------------------------------------------------------------------------------
Secure your life and health
✔️Policy Bazaar:
____________________________________________________________________

What is covered?
00:00 - Introduction
01:47 - What does the company do
03:55 - Industry Analysis
05:29 - What is generic and branded medicine
08:12 - Revenue Bifurcation
10:29 - Key risks
11:38 - Financials and Valuation
13:17 - Peer comparison
14:09 - Objects and details of the Issue

#CARachanaRanade #ShareMarket #ipo

[CARachanaRanade]

Correction:
🔴07:28 - Correction: from Generic* vs from Branded patented products.
Clarification- 09:08 - API image is taken from Emcure's website

[ShrenikBhura]

In pharma -
Generics not same as off-patent. For e.g. paracetamol
Branded not same as patented. For e.g. Crocin

[AkashYadavOriginal]

Branded Generics are still Generics. It is like selling Paracetamol as Paracetamol vs marketting it as Dolo or Crocin. Their actual patented products are too less.

[vibhashsrivastava]

Watching your video after long gap....very much delighted to see you as I am thinking about this particular ipo ..and here u r on my screen 😂

[harshitasaxena]

Mam pls mention ur view also whether to go for emmcure ipo or its 50-50 chance

[riddhisweety]

Love you darling 😘. Tu khup ladies la financial shikavlet. Including me

[Vikashtezu]

I was waiting for your video on emcure... You are late... I have applied for the ipo

[gauru]

it is commendable that inspite of knowing Namita personally, you were neutral in this video...signs of a great vlogger...kudos Rachana Tai...

[serotonin]

I have question on nps... would you answer that plz...
My office has alloted standard scheme under sbi+uti+lic but they are giving minus returns...so should I change my scheme to another scheme and auto mode with another pension manager like icici or hdfc

[mr.mehetaj]

SCENARIO1(CAPITALGAIN) I have a question if I buy 100 shares of (ABC) company and after 1 year my share becomes Rs 1 lakh plus profit, if I sell that share at 50% mean 50 shares then how much tax will I have to pay?? SCENARIO 2 If I buy 100 shares of (ABC) company and 100 shares of (DEF) company, after 1 year my profit will be Rs 2 lakhs, then if I sell 50% shares of both, how much tax will I have to pay on the profit of Rs 1 lakh. In capital gain tax assumption, I have bought shares of 10 companies and made 50k profit per company share through harvesting every month. Over all 10 months I have harvested 5 lakh profit, how much tax will I be charged as ltcgt., reply

[Budruk]

Very well explained Ma'am. Thanks

[navindharod]

As you wish, Apply, I will take the benefit of euphoria in market, sell instantly if alloted.... little risk taking banta hai😊

[shrutanjoyadak]

Do you know govt of india will be challenging patented products if they provide significant OS ?

[funnyritz]

09:19 LOL...So cute Rachna haha, thanks for an amazing presentation.

[vamsikrishna]

Mam need your advise, Should I apply or not?

[pradnyapatwardhan]

Mam, many times we don’t get allotted IPO because of institutional buyers.Nothing happens only blockage of funds. What’s use of application?

[GodofTechnologies]

ह्म... पुणेकर पुणेकर 😊, So Ma'em Does Namita T. Have expertise in there core business? 🤪

[PratikDas-vubs]

That's where Rachna ma'am entered when someone has no expertise on it 😂😂😂

[paradhye]

Good info and based on analysis company performance is not upto mark so be cautious

[Dakshinian]

Saavy investors should never buy IPO due to premium valuation. Wait for ‘honeymoon’ period to be over which is first 100 days after IPO release.